Non-CE Industry Poster Presentation: Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhage: A Prospective Randomized Trial (Sponsored by Grace Therapeutics)
3:15 PM - 3:30 PM CT
Non-CE Industry Poster Presentation: Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhage: A Prospective Randomized Trial (Sponsored by Grace Therapeutics)
Location: Back of Exhibit Hall, Near the AANN Booth
Secret Weapon Attack or Mass Psychogenic Illness? The Role of Flawed Science, Diplomatic Intrigue, and Media Sensationalism in the Continued Mystery of ‘Havana Syndrome.’
3:40 PM - 4:40 PM CT
(119) Secret Weapon Attack or Mass Psychogenic Illness? The Role of Flawed Science, Diplomatic Intrigue, and Media Sensationalism in the Continued Mystery of ‘Havana Syndrome’
Non-CE Industry Poster Presentation: Final Results from a Long-Term Open Label Extension Study (Up to 4 Years): Tolerability of Fenfluramine and Global Functioning of Pediatric and Adult Patients with Dravet or Lennox-Gastaut Syndromes (Sponsored by UCB, Inc.)
5:45 PM - 6:00 PM CT
Non-CE Industry Poster Presentation: Final Results from a Long-Term Open Label Extension Study (Up to 4 Years): Tolerability of Fenfluramine and Global Functioning of Pediatric and Adult Patients with Dravet or Lennox-Gastaut Syndromes (Sponsored by UCB, Inc.)
Location: Back of Exhibit Hall, Near the AANN Booth
The Path to Developing a National Association of Epilepsy Centers-Accredited Pediatric Epilepsy Monitoring Unit: Review of Essential Components and Required Processes
11:25 AM - 11:55 AM CT
(212) The Path to Developing a National Association of Epilepsy Centers-Accredited Pediatric Epilepsy Monitoring Unit: Review of Essential Components and Required Processes